Inventor · disambiguated record
Sangkil Nam
Also filed as: NAM SANGKIL
19 granted patents·7 pending applications·64 citations·filing 2001–2024
92Inventor score
Top patents by PatentIndex Score
26 records- 0194US9828342B2Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereofHOPE CITY·Filed 2013·Granted Nov 28, 2017·19 cites·8 claims
- 0288US6713506B2Tea polyphenol esters and analogs thereof for cancer prevention and treatmentUNIV SOUTH FLORIDA·Filed 2001·Granted Mar 30, 2004·26 cites·15 claims
- 0385US11306072B25-bromo-indirubinsHOPE CITY·Filed 2020·Granted Apr 19, 2022·2 cites·3 claims
- 0484US10703718B25-bromo-indirubinsHOPE CITY·Filed 2018·Granted Jul 7, 2020·2 cites·18 claims
- 0584US9856273B2ETP derivativesHOPE CITY·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 0684US9527868B2ETP derivativesHOPE CITY·Filed 2015·Granted Dec 27, 2016·3 cites·15 claims
- 0782US10435367B2Indirubin derivatives, and uses thereofHOPE CITY·Filed 2013·Granted Oct 8, 2019·3 cites·13 claims
- 0876US9512076B2Indirubin derivatives and uses thereof in treating chronic myelogenous leukemiaHOPE CITY·Filed 2013·Granted Dec 6, 2016·2 cites·3 claims
- 0974US10246471B2ETP derivativesHOPE CITY·Filed 2017·Granted Apr 2, 2019·1 cites·21 claims
- 1073US8722698B2Berbamine derivativesHORNE DAVID·Filed 2010·Granted May 13, 2014·2 cites·9 claims
- 1170US10822353B2Dithio ETP derivativesHOPE CITY·Filed 2017·Granted Nov 3, 2020·1 cites·34 claims
- 1270US2022274964A15-bromo-indirubinsHOPE CITY·Filed 2022·Application pending·0 cites
- 1368US11964941B25-Bromo-indirubinsHOPE CITY·Filed 2020·Granted Apr 23, 2024·0 cites·16 claims
- 1467US7615638B2Synthesis of grossularines-1 and analogs thereof and method of useHOPE CITY·Filed 2007·Granted Nov 10, 2009·1 cites·16 claims
- 1565US11524937B2Indirubin derivatives, and uses thereofHOPE CITY·Filed 2019·Granted Dec 13, 2022·0 cites·14 claims
- 1665US2025152593A1p38 MAPK INHIBITORS AND USES THEREOFHOPE CITY·Filed 2024·Application pending·0 cites
- 1761US11766442B2T-cell lymphoma treatmentsHOPE CITY·Filed 2018·Granted Sep 26, 2023·0 cites·5 claims
- 1860US9233976B2Berbamine derivativesHOPE CITY·Filed 2014·Granted Jan 12, 2016·0 cites·5 claims
- 1959US2023174483A1Indirubin derivatives, and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2058US11584760B2Dithio ETP derivativesHOPE CITY·Filed 2020·Granted Feb 21, 2023·0 cites·19 claims
- 2158US2018170915A15-bromo-indirubinsHOPE CITY·Filed 2018·Application pending·0 cites
- 2256US2016068517A15-bromo-indirubinsHOPE CITY·Filed 2015·Application pending·0 cites
- 2353US2015259288A15-bromo-indirubinsHOPE CITY·Filed 2015·Application pending·0 cites
- 2446US2023190717A1P38 gamma inhibitors and method of use thereofHOPE CITY·Filed 2018·Application pending·0 cites
- 2537US11213510B2ThioindirubinsHOPE CITY·Filed 2018·Granted Jan 4, 2022·0 cites·32 claims
- 2636US11117894B2Pyridopyrazine compounds and uses thereofHOPE CITY·Filed 2018·Granted Sep 14, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Sangkil Nam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →